Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2025	Dec. 31, 2024
Cash and cash equivalents
Restricted cash	$ 180	$ 427
Accumulated depreciation and amortization	11,130	10,739
Other assets, reserves for credit losses	23	27
Liabilities
Long-term debt	$ 51,236	$ 49,715
Shareholders’ Equity
Preferred shares, par value (in dollars per share)	$ 1.667	$ 1.667
Preferred shares authorized (in shares)	20,000,000	20,000,000
Preferred shares, issued (in shares)	1,600	1,600
Preferred shares, outstanding (in shares)	1,600	1,600
Common shares, par value (in dollars per share)	$ 0.20	$ 0.20
Common shares, authorized (in shares)	3,600,000,000	3,600,000,000
Common shares, issued (in shares)	701,000,000	702,000,000
Common shares, outstanding (in shares)	701,000,000	702,000,000
Card Member Receivables
Cash and cash equivalents
Financing receivables, gross	$ 58,503	$ 59,411
Allowance for credit losses	148	171
Card Member Loans
Cash and cash equivalents
Financing receivables, gross	139,203	139,674
Allowance for credit losses	5,592	5,679
Other Loans
Cash and cash equivalents
Financing receivables, gross	9,678	9,232
Allowance for credit losses	244	194
Variable Interest Entity, Primary Beneficiary
Cash and cash equivalents
Restricted cash	14	6
Restricted investments	88	82
Liabilities
Long-term debt	14,029	13,880
Variable Interest Entity, Primary Beneficiary | Card Member Receivables
Cash and cash equivalents
Financing receivables, gross	4,205	3,927
Variable Interest Entity, Primary Beneficiary | Card Member Loans
Cash and cash equivalents
Financing receivables, gross	$ 26,667	$ 28,278